FDA reclassifies medical image analysers
Singapore, Jan. 23 -- The US Food and Drug Administration (USFDA) has issued a final order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast lesions, radiograph lung nodules, and radiograph dental caries detection, postamendments class III devices (regulated under product code MYN), into class II (special controls), subject to premarket notification.
These devices are intended to direct the clinician's attention to portions of an image that may reveal abnormalities during interpretation of patient radiology images by the clinician.
FDA is also identifying the special controls that the Agency believes are necessary to provide a reasonable assurance of safety and effectiveness of the device type...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.